N- [(6-aza-bicyclo[3.2.1]oct-5-yl)-aryl-meth yl]-heterobenzamide derivatives, preparation thereof, and therapeutic use of same

Details for Australian Patent Application No. 2010224721 (hide)

Owner Sanofi

Inventors Estenne-Bouhtou, Genevieve; Medaisko, Florence

Agent A J Park

Pub. Number AU-A-2010224721

PCT Pub. Number WO2010/106270

Priority 09/01220 16.03.09 FR

Filing date 15 March 2010

Wipo publication date 23 September 2010

International Classifications

C07D 487/08 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/403 (2006.01) - condensed with carbocyclic rings, e.g. carbazole

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

6 October 2011 PCT application entered the National Phase

  PCT publication WO2010/106270 Priority application(s): WO2010/106270

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010224746-Floating platform for extracting wind energy

2010224720-Derivatives of N-[(2-aza-bicyclo [2.1.1]hex-1-yl)-aryl-methyl]-heterobenz amide, preparation thereof and application of same in therapeutics